Table 4—

Forced expiratory volume in one second(FEV1) and diffusing capacity of the lung for carbon monoxide (DL,CO) measurements

Type 1 diabetesType 2 diabetes
Subjects nMean±sdSubjects nMean±sd
FEV1 L
 Baseline (week 0)203.65±0.79243.49±0.59
 SC (week 11)203.66±0.78233.63±0.52
 Change SC-baseline200.011±0.16230.061±0.16
 EXU (week 24)203.60±0.77213.39±0.60
 Change EXU-SC20-0.067±0.1120-0.027±0.14
 2-week follow-up193.58±0.82243.45±0.61
DL,CO mL·min−1·mmHg−1
 Baseline (week 0)2028.32±6.332428.91±5.43
 SC (week 11)2028.02±6.362327.76±4.55
 Change SC-baseline20-0.303±1.8623-0.676±1.41
 EXU (week 24)2027.32±6.162126.95±4.74
 Change EXU-SC20-0.699±2.1120-0.902±1.21
 2-week follow-up1927.86±6.122427.96±4.53
  • SC: subcutaneous; EXU: Exubera®.